As at Jul 13, 2026, the TECH stock has a PE ratio of 100.51. This is based on the current EPS of $0.71 and the stock price of $71.36 per share. The current PE ratio is comparable to the past four-quarter average.
The mean historical PE ratio of BIO-TECHNE over the last ten years is 64.79. The current 100.51 PE ratio is 55% above the historical average. Over the past ten years, TECH's PE ratio was at its highest in the Jun 2021 quarter at 123.7, with a price of $112.57 and an EPS of $0.91. The Sep 2022 quarter recorded the bottom point at 38.17, with a price of $71 and an EPS of $1.86.
Maximum annual increase: 181.07% in 2021
Maximum annual decrease: -59.51% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 109.47 | 63.49% | $51.45 | $0.47 |
| 2024 | 66.96 | 48.47% | $71.65 | $1.07 |
| 2023 | 45.1 | -9.96% | $81.63 | $1.81 |
| 2022 | 50.09 | -59.51% | $86.66 | $1.73 |
| 2021 | 123.7 | 181.07% | $112.57 | $0.91 |
| 2020 | 44.01 | -45.96% | $66.02 | $1.5 |
| 2019 | 81.44 | 84.96% | $52.12 | $0.64 |
| 2018 | 44.03 | -23.56% | $36.99 | $0.84 |
| 2017 | 57.6 | 43.03% | $29.38 | $0.51 |
| 2016 | 40.27 | 17.78% | $28.19 | $0.7 |
| 2015 | 34.19 | 10.79% | $24.62 | $0.72 |
| 2014 | 30.86 | 37.58% | $23.14 | $0.75 |
| 2013 | 22.43 | -8.11% | $17.27 | $0.77 |
| 2012 | 24.41 | -11.01% | $18.55 | $0.76 |
| 2011 | 27.43 | 41.32% | $20.84 | $0.76 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 73.61 | -34.92% | $52.26 | $0.71 |
| Dec 2025 | 113.1 | 1.65% | $58.81 | $0.52 |
| Sep 2025 | 111.26 | 1.64% | $55.63 | $0.5 |
| Jun 2025 | 109.47 | 54.97% | $51.45 | $0.47 |
| Mar 2025 | 70.64 | -1.93% | $58.63 | $0.83 |
| Dec 2024 | 72.03 | -14.39% | $72.03 | $1 |
| Sep 2024 | 84.14 | 25.66% | $79.93 | $0.95 |
| Jun 2024 | 66.96 | 20.8% | $71.65 | $1.07 |
| Mar 2024 | 55.43 | 1.3% | $70.39 | $1.27 |
| Dec 2023 | 54.72 | 25.42% | $77.16 | $1.41 |
| Sep 2023 | 43.63 | -3.26% | $68.07 | $1.56 |
| Jun 2023 | 45.1 | 5.18% | $81.63 | $1.81 |
| Mar 2023 | 42.88 | -13.6% | $74.19 | $1.73 |
| Dec 2022 | 49.63 | 30.02% | $82.88 | $1.67 |
| Sep 2022 | 38.17 | -23.8% | $71 | $1.86 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of TECH is greater than its 3, 5 and 10-year historical averages.
With a P/E of 100.51, TECH is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 25.82, BIO-TECHNE's P/E is 289% higher.
TECH's PE ratio is higher than its peer stocks GE and TMO. BIO-TECHNE is presently trading at a higher PE ratio (100.51) than its peer group average of 31.9.
| Stock name | PE ratio | Market cap |
|---|---|---|
| STEM Stem Inc | 0.38 | $58.4M |
| QGEN Qiagen NV | 22.16 | $8.57B |
| TMO Thermo Fisher Scientific Inc | 29.01 | $196.41B |
| DHR Danaher Corp | 38.57 | $141.67B |
| BDX Becton Dickinson & Co | 38.94 | $42.39B |
| GE General Electric Co | 43.21 | $368.74B |
| BIO Bio-Rad Laboratories Inc | 51.04 | $7.96B |
| TECH BIO-TECHNE Corp | 100.51 | $11.17B |
The price to earnings ratio for TECH stock as of Jul 13, 2026, stands at 100.51.
Over the last 3 years, the average price to earnings ratio for TECH stock is 77.73.
Over the last 5 years, the average price to earnings ratio for TECH stock is 71.45.
In the last ten years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 123.7.
TECH's current price to earnings ratio is 55% above its 10-year historical average.
TECH's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 13, 2026), BIO-TECHNE's stock price is $71.36. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.71. Therefore, BIO-TECHNE's P/E ratio for today is 100.51. PE RATIO(100.51) = STOCK PRICE($71.36) / TTM EPS($0.71)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.